Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02547675
Title Rociletinib (CO-1686) USA Expanded Access Program
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Scottsdale Arizona 85024 United States Details
Compassionate Care Research Group, Inc. Fountain Valley California 92866 United States Details
Pacific Cancer Care Monterey California 93940 United States Details
Sutter Cancer Institute Sacramento California 95816 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
Halifax Health - Center for Oncology Daytona Beach Florida 32114 United States Details
UF Health Center Orlando Orlando Florida 32806 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Billings Clinic Billings Montana 59101 United States Details
Tulsa Cancer Institute Tulsa Oklahoma 74146 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field